0
     

Report Added
Report already added
Automation in Biopharma Market in China - Industry Outlook and Forecast 2020-2026

Automation in Biopharma Market in China - Industry Outlook and Forecast 2020-2026

This report contains market size and forecasts of Automation in Biopharma in China, including the following market information:
China Automation in Biopharma Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in China Automation in Biopharma Market 2019 (%)
The global Automation in Biopharma market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Automation in Biopharma market size in China was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
Total Market by Segment:
China Automation in Biopharma Market, By Type, 2015-2020, 2021-2026 ($ millions)
China Automation in Biopharma Market Segment Percentages, By Type, 2019 (%)
IoT
AI
Digital Twin
AR & VR
Predictive Analytics
Cloud Computing

China Automation in Biopharma Market, By Application, 2015-2020, 2021-2026 ($ millions)
China Automation in Biopharma Market Segment Percentages, By Application, 2019 (%)
Large Pharmaceutical Factory
Small and Medium-sized Pharmaceutical Factory
Biopharmaceutical Laboratory
Other

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Automation in Biopharma Market Competitors Revenues in China, by Players 2015-2020 (Estimated), ($ millions)
Total Automation in Biopharma Market Competitors Revenues Share in China, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
GE
PerkinElmer
Tecan Journal
Thermo Fisher Scientific
Bruker Corporation
Peak Analysis & Automation
Sartorius
Siemens
Rockwell
Zenith (Cognizant)
RheoSense, Inc.
Werum
Emerson
TetraScience
BioProcess International
Novasep
1 Introduction to Research & Analysis Reports
1.1 Automation in Biopharma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 China Automation in Biopharma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 China Automation in Biopharma Overall Market Size
2.1 China Automation in Biopharma Market Size: 2020 VS 2026
2.2 China Automation in Biopharma Revenue, Prospects & Forecasts: 2015-2026

3 Company Landscape
3.1 Top Automation in Biopharma Players in China (including Foreign and Local Companies)
3.2 Top China Automation in Biopharma Companies Ranked by Revenue
3.3 China Automation in Biopharma Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Automation in Biopharma Companies in China, by Revenue in 2019
3.5 China Manufacturers Automation in Biopharma Product Type
3.6 Tier 1, Tier 2 and Tier 3 Automation in Biopharma Players in China
3.6.1 List of China Tier 1 Automation in Biopharma Companies
3.6.2 List of China Tier 2 and Tier 3 Automation in Biopharma Companies

4 Market Sights by Product
4.1 Overview
4.1.1 By Type - China Automation in Biopharma Market Size Markets, 2020 & 2026
4.1.2 IoT
4.1.3 AI
4.1.4 Digital Twin
4.1.5 AR & VR
4.1.6 Predictive Analytics
4.1.7 Cloud Computing
4.2 By Type - China Automation in Biopharma Revenue & Forecasts
4.2.1 By Type - China Automation in Biopharma Revenue, 2015-2020
4.2.2 By Type - China Automation in Biopharma Revenue, 2021-2026
4.2.3 By Type - China Automation in Biopharma Revenue Market Share, 2015-2026
5 Market Sights by Application
5.1 Overview
5.1.1 By Application - China Automation in Biopharma Market Size, 2020 & 2026
5.1.2 Large Pharmaceutical Factory
5.1.3 Small and Medium-sized Pharmaceutical Factory
5.1.4 Biopharmaceutical Laboratory
5.1.5 Other
5.2 By Application - China Automation in Biopharma Revenue & Forecasts
5.2.1 By Application - China Automation in Biopharma Revenue, 2015-2020
5.2.2 By Application - China Automation in Biopharma Revenue, 2021-2026
5.2.3 By Application - China Automation in Biopharma Revenue Market Share, 2015-2026
6 Players Profiles
6.1 GE
6.1.1 GE Corporate Summary
6.1.2 GE Business Overview
6.1.3 GE Automation in Biopharma Major Product Offerings
6.1.4 GE Revenue in China (2015-2020)
6.1.5 GE Key News
6.2 PerkinElmer
6.2.1 PerkinElmer Corporate Summary
6.2.2 PerkinElmer Business Overview
6.2.3 PerkinElmer Automation in Biopharma Major Product Offerings
6.2.4 PerkinElmer Revenue in China (2015-2020)
6.2.5 PerkinElmer Key News
6.3 Tecan Journal
6.3.1 Tecan Journal Corporate Summary
6.3.2 Tecan Journal Business Overview
6.3.3 Tecan Journal Automation in Biopharma Major Product Offerings
6.3.4 Tecan Journal Revenue in China (2015-2020)
6.3.5 Tecan Journal Key News
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporate Summary
6.4.2 Thermo Fisher Scientific Business Overview
6.4.3 Thermo Fisher Scientific Automation in Biopharma Major Product Offerings
6.4.4 Thermo Fisher Scientific Revenue in China (2015-2020)
6.4.5 Thermo Fisher Scientific Key News
6.5 Bruker Corporation
6.5.1 Bruker Corporation Corporate Summary
6.5.2 Bruker Corporation Business Overview
6.5.3 Bruker Corporation Automation in Biopharma Major Product Offerings
6.5.4 Bruker Corporation Revenue in China (2015-2020)
6.5.5 Bruker Corporation Key News
6.6 Peak Analysis & Automation
6.6.1 Peak Analysis & Automation Corporate Summary
6.6.2 Peak Analysis & Automation Business Overview
6.6.3 Peak Analysis & Automation Automation in Biopharma Major Product Offerings
6.6.4 Peak Analysis & Automation Revenue in China (2015-2020)
6.6.5 Peak Analysis & Automation Key News
6.7 Sartorius
6.6.1 Sartorius Corporate Summary
6.6.2 Sartorius Business Overview
6.6.3 Sartorius Automation in Biopharma Major Product Offerings
6.4.4 Sartorius Revenue in China (2015-2020)
6.7.5 Sartorius Key News
6.8 Siemens
6.8.1 Siemens Corporate Summary
6.8.2 Siemens Business Overview
6.8.3 Siemens Automation in Biopharma Major Product Offerings
6.8.4 Siemens Revenue in China (2015-2020)
6.8.5 Siemens Key News
6.9 Rockwell
6.9.1 Rockwell Corporate Summary
6.9.2 Rockwell Business Overview
6.9.3 Rockwell Automation in Biopharma Major Product Offerings
6.9.4 Rockwell Revenue in China (2015-2020)
6.9.5 Rockwell Key News
6.10 Zenith (Cognizant)
6.10.1 Zenith (Cognizant) Corporate Summary
6.10.2 Zenith (Cognizant) Business Overview
6.10.3 Zenith (Cognizant) Automation in Biopharma Major Product Offerings
6.10.4 Zenith (Cognizant) Revenue in China (2015-2020)
6.10.5 Zenith (Cognizant) Key News
6.11 RheoSense, Inc.
6.11.1 RheoSense, Inc. Corporate Summary
6.11.2 RheoSense, Inc. Automation in Biopharma Business Overview
6.11.3 RheoSense, Inc. Automation in Biopharma Major Product Offerings
6.11.4 RheoSense, Inc. Revenue in China (2015-2020)
6.11.5 RheoSense, Inc. Key News
6.12 Werum
6.12.1 Werum Corporate Summary
6.12.2 Werum Automation in Biopharma Business Overview
6.12.3 Werum Automation in Biopharma Major Product Offerings
6.12.4 Werum Revenue in China (2015-2020)
6.12.5 Werum Key News
6.13 Emerson
6.13.1 Emerson Corporate Summary
6.13.2 Emerson Automation in Biopharma Business Overview
6.13.3 Emerson Automation in Biopharma Major Product Offerings
6.13.4 Emerson Revenue in China (2015-2020)
6.13.5 Emerson Key News
6.14 TetraScience
6.14.1 TetraScience Corporate Summary
6.14.2 TetraScience Automation in Biopharma Business Overview
6.14.3 TetraScience Automation in Biopharma Major Product Offerings
6.14.4 TetraScience Revenue in China (2015-2020)
6.14.5 TetraScience Key News
6.15 BioProcess International
6.15.1 BioProcess International Corporate Summary
6.15.2 BioProcess International Automation in Biopharma Business Overview
6.15.3 BioProcess International Automation in Biopharma Major Product Offerings
6.15.4 BioProcess International Revenue in China (2015-2020)
6.15.5 BioProcess International Key News
6.16 Novasep
6.16.1 Novasep Corporate Summary
6.16.2 Novasep Automation in Biopharma Business Overview
6.16.3 Novasep Automation in Biopharma Major Product Offerings
6.16.4 Novasep Revenue in China (2015-2020)
6.16.5 Novasep Key News

7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for China Automation in Biopharma Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints

8 Conclusion

9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 DisclaimerList of Tables
Table 1. Key Players of Automation in Biopharma in China
Table 2. Top Players in China, Ranking by Revenue (2019)
Table 3. China Automation in Biopharma Revenue by Companies, (US$, Mn), 2015-2020
Table 4. China Automation in Biopharma Revenue Share by Companies, 2015-2020
Table 5. China Automation in Biopharma Sales by Companies, (K Units), 2015-2020
Table 6. China Automation in Biopharma Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Automation in Biopharma Price (2015-2020) (US$/Unit)
Table 8. China Manufacturers Automation in Biopharma Product Type
Table 9. List of China Tier 1 Automation in Biopharma Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of China Tier 2 and Tier 3 Automation in Biopharma Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Automation in Biopharma Revenue in China (US$, Mn), 2015-2020
Table 12. By Type - Automation in Biopharma Revenue in China (US$, Mn), 2021-2026
Table 13. By Type - Automation in Biopharma Sales in China (K Units), 2015-2020
Table 14. By Type - Automation in Biopharma Sales in China (K Units), 2021-2026
Table 15. By Application - Automation in Biopharma Revenue in China, (US$, Mn), 2015-2020
Table 16. By Application - Automation in Biopharma Revenue in China, (US$, Mn), 2021-2026
Table 17. By Application - Automation in Biopharma Sales in China, (K Units), 2015-2020
Table 18. By Application - Automation in Biopharma Sales in China, (K Units), 2021-2026
Table 19. GE Corporate Summary
Table 20. GE Automation in Biopharma Product Offerings
Table 21. GE Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 22. PerkinElmer Corporate Summary
Table 23. PerkinElmer Automation in Biopharma Product Offerings
Table 24. PerkinElmer Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 25. Tecan Journal Corporate Summary
Table 26. Tecan Journal Automation in Biopharma Product Offerings
Table 27. Tecan Journal Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 28. Thermo Fisher Scientific Corporate Summary
Table 29. Thermo Fisher Scientific Automation in Biopharma Product Offerings
Table 30. Thermo Fisher Scientific Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 31. Bruker Corporation Corporate Summary
Table 32. Bruker Corporation Automation in Biopharma Product Offerings
Table 33. Bruker Corporation Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 34. Peak Analysis & Automation Corporate Summary
Table 35. Peak Analysis & Automation Automation in Biopharma Product Offerings
Table 36. Peak Analysis & Automation Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 37. Sartorius Corporate Summary
Table 38. Sartorius Automation in Biopharma Product Offerings
Table 39. Sartorius Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 40. Siemens Corporate Summary
Table 41. Siemens Automation in Biopharma Product Offerings
Table 42. Siemens Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 43. Rockwell Corporate Summary
Table 44. Rockwell Automation in Biopharma Product Offerings
Table 45. Rockwell Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 46. Zenith (Cognizant) Corporate Summary
Table 47. Zenith (Cognizant) Automation in Biopharma Product Offerings
Table 48. Zenith (Cognizant) Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 49. RheoSense, Inc. Corporate Summary
Table 50. RheoSense, Inc. Automation in Biopharma Product Offerings
Table 51. RheoSense, Inc. Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 52. Werum Corporate Summary
Table 53. Werum Automation in Biopharma Product Offerings
Table 54. Werum Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 55. Emerson Corporate Summary
Table 56. Emerson Automation in Biopharma Product Offerings
Table 57. Emerson Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 58. TetraScience Corporate Summary
Table 59. TetraScience Automation in Biopharma Product Offerings
Table 60. TetraScience Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 61. BioProcess International Corporate Summary
Table 62. BioProcess International Automation in Biopharma Product Offerings
Table 63. BioProcess International Automation in Biopharma Revenue (US$, Mn), (2015-2020)
Table 64. Novasep Corporate Summary
Table 65. Novasep Automation in Biopharma Product Offerings
Table 66. Novasep Automation in Biopharma Revenue (US$, Mn), (2015-2020)
List of Figures
Figure 1. Automation in Biopharma Segment by Type
Figure 2. Automation in Biopharma Segment by Application
Figure 3. China Automation in Biopharma Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Automation in Biopharma Market Size in China, (US$, Mn): 2020 VS 2026
Figure 6. China Automation in Biopharma Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Automation in Biopharma Revenue in 2019
Figure 8. By Type - China Automation in Biopharma Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - China Automation in Biopharma Market Share, 2015-2026
Figure 10. By Application - Automation in Biopharma Revenue in China (US$, Mn), 2020 & 2026
Figure 11. By Application - China Automation in Biopharma Market Share, 2015-2026
Figure 12. PEST Analysis for China Automation in Biopharma Market in 2020
Figure 13. Automation in Biopharma Market Opportunities & Trends in China
Figure 14. Automation in Biopharma Market Drivers in China

Report Title: Automation in Biopharma Market in China - Industry Outlook and Forecast 2020-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW